WITHDRAWN: Comparative evaluation of two vaginal self-sampling devices for the detection of human papillomavirus infections

M. Jentschke1, K. Chen1,2, M. Arbyn3, B. Hertel1, M. Noskowicz1, P. Soergel1, P. Hillemanns1
1Department of Gynaecology and Obstetrics, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany
2Department of Gynaecology and Obstetrics, Tongji Hospital, Tongji University, Xin Cun Road 389#, 200065 Shanghai, China
3Scientific Institute of Public Health (WIV-ISP), 14, Rue Juliette Wytsman, 1050 Brussels, Belgium

Tài liệu tham khảo

Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J. Pathol., 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Ronco, 2014, Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials, Lancet, 383, 524, 10.1016/S0140-6736(13)62218-7 Arbyn, 2012, Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer, Vaccine, 30, F88, 10.1016/j.vaccine.2012.06.095 Arbyn, 2015, Cervical cancer screening program and human Papillomavirus (HPV) testing Saslow, 2012, American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer, CA Cancer J. Clin., 62, 147, 10.3322/caac.21139 Medical Services Advisory Committee (MSAC). Application No. 1276–Renewal of the National Cervical Screening Program. Australian Government, Department of Health, 2014. Elfstrom, 2015, Cervical cancer screening in Europe: quality assurance and organisation of programmes, Eur. J. Cancer, 51, 950, 10.1016/j.ejca.2015.03.008 Geyer, 2014, Cervical cancer screening in Germany: group-specific participation rates in the state of Niedersachsen (Lower Saxony). A study with health insurance data, Arch. Gynecol. Obstet., 291, 623, 10.1007/s00404-014-3421-3 Marquardt, 2011, Persistent carcinoma in cervical cancer screening: non-participation is the most significant cause, Acta Cytol., 55, 433, 10.1159/000331811 Andrae, 2008, Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden, J. Natl. Cancer Inst., 100, 622, 10.1093/jnci/djn099 Leyden, 2005, Cervical cancer in women with comprehensive health care access: attributable factors in the screening process, J. Natl. Cancer Inst., 97, 675, 10.1093/jnci/dji115 Sung, 2000, Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan, Cancer, 88, 2283, 10.1002/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.0.CO;2-D Zaal, 2015, The diagnostic process of cervical cancer; areas of good practice, and windows of opportunity, Gynecol. Oncol., 138, 405, 10.1016/j.ygyno.2015.05.037 Arbyn, 2015, Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program, Cancer Epidemiol. Biomark. Prev., 24, 769, 10.1158/1055-9965.EPI-14-1417 Arbyn, 2014, Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis, Lancet Oncol., 15, 172, 10.1016/S1470-2045(13)70570-9 Poljak, 2013, The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies, Acta Dermatovenerol. Alp. Pannonica Adriat., 22, 43 Arbyn, 2015, Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?, Clin. Microbiol. Infect., 10.1016/j.cmi.2015.04.015 Jentschke, 2012, Evaluation of a new multiplex real-time polymerase chain reaction assay for the detection of human papillomavirus infections in a referral population, Int. J. Gynecol. Cancer, 22, 1050, 10.1097/IGC.0b013e31825529b7 Jentschke, 2013, Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples, J. Virol. Methods, 193, 131, 10.1016/j.jviromet.2013.05.009 Richart, 1973, Cervical intraepithelial neoplasia, Pathol. Annu., 8, 301 Fleiss, 1981 Jentschke, 2012, Prävention des Zervixkarzinoms. Das wird die neue S3-Leitlinie berücksichtigen, Gynäkologie+Geburtshilfe, 17, 22 Verdoodt, 2015, Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials, Eur. J. Cancer, 10.1016/j.ejca.2015.07.006 Gök, 2010, HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study, BMJ, 340, c1040, 10.1136/bmj.c1040 Hillemanns, 1999, Screening for cervical neoplasia by self-assessment for human papillomavirus DNA, Lancet, 354, 1970, 10.1016/S0140-6736(99)04110-0 Dannecker, 2004, Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics, Ann. Oncol., 15, 863, 10.1093/annonc/mdh240 Igidbashian, 2011, Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities, J. Womens Health (Larchmt), 20, 397, 10.1089/jwh.2010.2189 Bosgraaf, 2014, Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening, Int. J. Cancer, 136, 646 van, 2012, Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women, J. Clin. Microbiol., 50, 3937, 10.1128/JCM.01506-12 Sanner, 2009, Self-sampling of the vaginal fluid at home combined with high-risk HPV testing, Br. J. Cancer, 101, 871, 10.1038/sj.bjc.6605194 Stenvall, 2007, High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening, Acta Derm. Venereol., 87, 243, 10.2340/00015555-0205 Wikstrom, 2011, Self-sampling and HPV testing or ordinary pap-smear in women not regularly attending screening: a randomised study, Br. J. Cancer, 105, 337, 10.1038/bjc.2011.236 Gyllensten, 2011, Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer, Br. J. Cancer, 105, 694, 10.1038/bjc.2011.277 Lindell, 2012, Self-sampling of vaginal fluid and high-risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screening, BJOG., 119, 245, 10.1111/j.1471-0528.2011.03147.x Stenvall, 2006, Human papilloma virus testing of vaginal smear obtained with a novel self-sampling device, Acta Derm. Venereol., 86, 465, 10.2340/00015555-0123